Latest Industry Insights

Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.

David Curtin discusses how the integration of MALS detectors with Empower software enhances biopharmaceutical QC, aligns with evolving regulatory demands and supports the future of complex biologic product analysis.

Learn more about how AI is advancing the mRNA drug discovery pipeline and what we can expect to see in the future in this interview with Dr. Davide De Lucrezia.

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming next in cardiac care.

In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they are reshaping cervical cancer prevention.

As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.

Mushroom mycelium can be turned into high-quality insulation and other building materials. To learn more, Technology Networks spoke with the founder of MycoTile, a Kenyan company that specializes in mycelium-based construction materials.

In this interview, Susan Bird, senior manager at Thermo Fisher Scientific, discusses the analytical challenges of identifying low-level exposures and how cutting-edge mass spectrometry platforms are advancing exposomics research.

Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.

Discover how induced pluripotent stem cell technology is solving scale and consistency issues in mesenchymal stem/stromal cell therapy manufacturing and learn about Cynata’s ongoing clinical trials.